• Bleomycin Sulfate A8331: Protocol & QC Guide

  2026-09-18

  Bleomycin Sulfate (SKU A8331) provides a practical DNA strand break-induction tool for cell-based damage assays and bleomycin-associated pulmonary fibrosis research. It is suitable for controlled in vitro and in vivo model development, but its ethanol insolubility, solution-storage limitations, cell-dependent potency, and model-specific inflammatory effects require explicit formulation and QC controls.

• Meropenem in Carbapenem Resistance Research

  2026-09-18

  Meropenem supports reproducible susceptibility testing, resistance-phenotype profiling, and infection-model design across Gram-negative and Gram-positive systems. This guide translates recent carbapenemase-transmission findings into practical assay choices, controls, and troubleshooting steps without treating research data as clinical guidance.

• Brain-to-Spinal Control of Opioid Pain Hypersensitivity

  2026-09-17

  Yin et al. identify a brain-to-spinal µ-opioid pathway that links lateral parabrachial MOR neurons, hypothalamic dynorphin neurons, and spinal dorsal-horn KOR-GABA neurons to morphine-induced mechanical hypersensitivity and analgesic tolerance. The study shows that focal MOR activation can produce a paradoxical mechanical pain phenotype and provides a circuit framework for interpreting opioid receptor signaling in chronic pain research.

• LNP Charge and V-ATPase Shape Nucleic Acid Delivery

  2026-09-17

  The reference study identifies a synergistic relationship between LNP surface charge and the V-ATPase activity of recipient cells, linking vector properties with target-cell endo/lysosomal state. Its findings suggest that delivery optimization should evaluate both nanoparticle design and cellular physiology rather than treating organ tropism as a property determined by the LNP alone.

• ML385: Practical NRF2 Inhibition Workflows

  2026-09-16

  ML385 enables controlled pharmacological suppression of NRF2 for cancer therapeutic resistance, oxidative stress, and pathway-dependency studies. This practical guide connects dose-response design with orthogonal validation and extends the workflow to the NRF2-dependent osteoclast findings reported in the reference study.

• Malic-Acid LNPs Deliver Uricase circRNA in Mice

  2026-09-16

  This 2026 Nature Communications study develops malic-acid-derived lipid nanoparticles that deliver secretory uricase circRNA and combine antioxidant activity with low immunogenicity. In male mouse models, the selected LMA2-C10 formulation produced sustained urate lowering while reducing inflammation, fibrosis, arthritic pain, and renal injury, although translation beyond these preclinical models remains uncertain.

• GKT137831 for Nox1/Nox4 Redox Workflows

  2026-09-15

  GKT137831 enables pathway-proximal testing of Nox1/Nox4-driven oxidative stress across pulmonary vascular, fibrotic, and metabolic disease models. This guide combines concentration planning, orthogonal ROS readouts, membrane-injury assays, and troubleshooting strategies to distinguish upstream redox control from late ferroptosis events.

• EZ Cap Cy5 Firefly Luciferase mRNA: Readout Logic

  2026-09-15

  EZ Cap Cy5 Firefly Luciferase mRNA enables researchers to distinguish mRNA delivery from productive translation using complementary fluorescence and bioluminescence signals. This article presents a mechanistic framework for assay design, carrier comparison, and translational interpretation beyond conventional dual-reporter workflows.

• Indomethacin Workflows for AKI Inflammation Research

  2026-09-14

  Indomethacin provides a practical COX-centered perturbation tool for separating prostaglandin-linked inflammation from the FXR–KLF11–JAK2/STAT3 mechanism reported in contrast-induced acute kidney injury. This guide translates the reference findings into cell-based assay design while extending the compound’s use to lipid metabolism study and membrane signaling modulation.

• Tauroursodeoxycholic Acid: ER Stress Workflows

  2026-09-14

  Tauroursodeoxycholic Acid, or TUDCA, is a practical chemical-chaperone tool for separating ER stress, mitochondrial injury, apoptosis, and autophagy in disease models. This guide translates ER stress findings from subarachnoid hemorrhage research into controlled cell-based workflows, assay choices, and troubleshooting strategies.

• Separating Growth Arrest from Cell Death in Cancer Assays

  2026-09-13

  Schwartz’s dissertation distinguishes relative viability from fractional viability, showing why a single in vitro endpoint can obscure whether a cancer drug primarily slows proliferation, induces cell death, or does both. Its timing- and response-oriented framework supports more rigorous interpretation of checkpoint-directed therapies and drug combinations.

• Sulfo-Cy3 NHS Ester: Hydrophilic Fluorescent Dye

  2026-09-12

  Sulfo-Cy3 NHS Ester is a hydrophilic fluorescent dye for aqueous labeling of primary amines in proteins and peptides. Its sulfonated structure, Cy3 spectral profile, and NHS ester chemistry support protein conjugation workflows for soluble and challenging biomolecular targets.

• Cy5 amine (non-sulfonated): Labeling Guide

  2026-09-11

  Cy5 amine (non-sulfonated) provides a primary amine for covalent attachment of a red-shifted cyanine fluorophore to activated biomolecule partners. It is suited to organic or mixed-solvent labeling workflows, but is insoluble in water and should not be used for direct aqueous dissolution, diagnostic testing, or medical applications.

• Griseofulvin: From Fungal Mitosis to Assays

  2026-09-11

  Explore how Griseofulvin functions as a microtubule associated inhibitor and how mechanism-resolved cytometry can sharpen antifungal drug research. This guide connects product handling, fungal mitosis biology, and aneugenic assay interpretation without conflating distinct experimental domains.

• Haloprogin: Applied Antifungal Research Workflows

  2026-09-10

  Haloprogin supports reproducible profiling across dermatophytes, Candida, and selected Gram-positive bacteria, with workflows spanning MIC/MFC testing and topical infection models. Its solvent, matrix, and formulation behavior make assay design especially important when translating in vitro potency into topical efficacy.

7795 records 1/520 page Next 12345 下5页 Last page